The DOI matches its Crossref record; 722 of the 722 references it cites were found in a registry or an index.
Current and Potential Drugs for Treatment of Obesity
Abstract
I. Introduction II. Criteria for Evaluating the Efficacy of Antiobesity Treatment III. Physiological and Pharmacological Mechanisms to Reduce Food Intake A. Peripherally acting agents B. Centrally acting agents IV. Drugs That Alter Metabolism A. Preabsorptive agents B. Postabsorptive modifiers of nutrient metabolism V. Drugs That Increase Energy Expenditure A. Thyroid hormone B. Adrenergic thermogenic drugs VI. Conclusion
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–722 of 722
Feeding Response to Mercaptoacetate in Osborne‐Mendel and S5B/PL Rats
Singer, L. K., York, D. A., & Bray, G. A. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00580.x · Cited by 24
Self-citationA pharmacodynamic interaction between caffeine and phenylpropanolamine
Brown, N. J., Ryder, D., & Branch, R. A. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.152 · Cited by 24
Winkler, G., Döring, A., & Keil, U. (2000) · Appetite · doi:10.1006/appe.1999.0273 · Cited by 24
Pharmacology of eating disorders : theoretical and clinical developments
Carruba, M. O., & Blundell, J. E. (1986) · Raven Press eBooks · Cited by 23
Obesity and weight control: The health professional's guide to understanding and treatment
Drewnowski, A. (1989) · Appetite · doi:10.1016/0195-6663(89)90018-4 · Cited by 23
Studies of the relationship between molecular structure and hallucinogenic activity
Nichols, D. E. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90362-x · Cited by 23
Effect of naltrexone on mood and cognitive functioning among overweight men
Hatsukami, D. K., Mitchell, J. E., Morley, J. E., Morgan, S. F., & Levine, A. S. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90050-8 · Cited by 23
Andelman, M. B., Jones, C., & Nathan, S. (1967) · Clinical Pediatrics · doi:10.1177/000992286700600607 · Cited by 23
Lunetta, M., Mauro, M. D., Moli, R. L., & Burrafato, S. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03349042 · Cited by 23
Static Theories in a Dynamic World: A Glucodynamic Theory of Food Intake
Bray, G. A. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00259.x · Cited by 23
Self-citationBorsini, F., Bendotti, C., Carli, M., Poggesi, E., & SAMANIN, R. (1979) · PubMed · Cited by 23
Effect of biguanide treatment in obese children.
Lütjens, A., & Jl, S. (1977) · PubMed · Cited by 23
Bray, G. A. (1979) · Disease-a-Month · doi:10.1016/s0011-5029(79)80003-6 · Cited by 23
Self-citationSandler, M., & Silverstone, T. (1985) · Oxford University Press eBooks · Cited by 22
Effect of amphetamine on human macronutrient intake
Foltin, R. W., Kelly, T. H., & F, M. W. (1995) · Physiology & Behavior · doi:10.1016/0031-9384(95)00149-d · Cited by 22
Prolactin response to dl-fenfluramine in panic disorder
Apostolopoulos, M., Judd, F. K., Burrows, G. D., & Norman, T. R. (1993) · Psychoneuroendocrinology · doi:10.1016/0306-4530(93)90009-a · Cited by 22
Structural determinants of oleoyl-estrone slimming effects
Sanchís, D., Balada, F., Farrerons, C. A., Virgili, J., Grasa, M., Adán, C., Esteve, M., Cabot, C., Ardèvol, A., Vilà, R., et al. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00069-1 · Cited by 22
Salmela, P. I., Sotaniemi, E. A., Viikari, J. S. A., SOLAKIVI‐JAAKKOLA, T., & Järvensivu, P. (1981) · Diabetes Care · doi:10.2337/diacare.4.5.535 · Cited by 22
Effects of vagotomy on satiety induced by gastrointestinal hormones in the rat
Taylor, I. L., García, R., & ELASHOFF, J. D. (1985) · Physiology & Behavior · doi:10.1016/0031-9384(85)90019-8 · Cited by 22
Lupien, J., & Bray, G. A. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90378-3 · Cited by 22
Self-citationRushing, P. A., Gibbs, J., & Geary, N. (1996) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00324-1 · Cited by 22
Comparison of Fluoxetine and Placebo in the Treatment of Obesity
Férnandez-Soto, M. L., nez, A. G. A. L.-J. E., Barredo-Acedo, F., delCastillo, L., & nez, F. E.-J. E. (1995) · Annals of Nutrition and Metabolism · doi:10.1159/000177857 · Cited by 22
Effect of 6 months therapy with dexfenfluramine in obese patients: studies in the United Kingdom.
Finer, N., Craddock, D., Lavielle, R., & Keen, H. I. (1988) · PubMed · Cited by 22
Thermogenic effect of the new beta-adrenoreceptor agonist Ro 16-8714 in healthy male volunteers.
Henny, C., Schutz, Y., Bückert, A., Meylan, M., Jéquier, E., & Jp, F. (1987) · PubMed · Cited by 22
The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Buemann, B., Marckmann, P., Christensen, N. J., & Astrup, A. V. (1994) · PubMed · Cited by 21
Bigelow, G. E., Griffiths, R. R., Liebson, I., & Kaliszak, J. E. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780230036005 · Cited by 21
Influence of orlistat on the regulation of gallbladder contraction in man
Froehlich, F., Hartmann, D., Güzelhan, C., Gonvers, J. J., Jansen, J. B. �. �., & Fried, M. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02100135 · Cited by 21
Linkage studies in NIDDM with markers near the sulphonylurea receptor gene
Stirling, B., Cox, N. J., Bell, G. I., Hanis, C. L., Spielman, R. S., & CONCANNON, P. J. (1995) · Diabetologia · doi:10.1007/bf00400610 · Cited by 21
The prolactin response to d- and I-fenfluramine and to d-amphetamine in human subjects
Feeney, S. P., Goodall, E., & Silverstone, T. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300810-00008 · Cited by 21
Changes of insulinemia, glycemia and feeding behavior induced by VMH-procainization in the rat
Berthoud, H. R., & Jeanrenaud, B. (1979) · Brain Research · doi:10.1016/0006-8993(79)90816-3 · Cited by 21
A double-blind trial of mazindol using a very low calorie formula diet.
Baird, I. M., & An, H. (1977) · PubMed · Cited by 21
Diethylpropion hydrochloride: an effective appetite suppressant.
Bolding, O. T. (1974) · PubMed · Cited by 21
Mechanisms of hypertension in obesity
Ovsyannikova, A. (2015) · Relevant endocrinology · doi:10.18508/endo1928 · Cited by 21
Relationship between food intake and metabolic rate in rats treated with beta-adrenoceptor agonists.
Yamashita, J.-I., Onai, T., York, D. A., & Bray, G. A. (1994) · PubMed · Cited by 20
Self-citationHypothalamic‐pituitary‐adrenal axis in abdominal obesity: effects of dexfenfluramine
Boushaki, F. Z., Rasio, E., & Serri, O. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1620975.x · Cited by 20
McAlpine, L. G., McAlpine, C., Waclawski, E., Storer, A., Kay, J., & Frier, B. M. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00614548 · Cited by 20
Coccaro, E. F., Klar, H., & Siever, L. J. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90633-5 · Cited by 20
Effects of peripheral neurotensin on behavior of the rat
Sandoval, S. L., & Kulkosky, P. J. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90115-v · Cited by 20
Ball, M. F., Kyle, L. H., & Canary, J. J. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-2-273 · Cited by 20
Effect of phenylpropanolamine on energy expenditure and weight loss in overweight women
Alger, S. A., Larson, K., Boyce, V., SEAGLE, H. M., Fontvieille, A. M., Ferraro, R., Rising, R., & Ravussin, É. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.2.120 · Cited by 20
Effect of physical training on thermogenic responses to cold and ephedrine in obesity.
Nielsen, B., Astrup, A. V., Samuelsen, P., Wengholt, H., & Christensen, N. (1993) · PubMed · Cited by 19
Characterization of bombesin binding sites in the rat stomach
Ladenheim, E. E., Moore, K. A., Salorio, C. F., Mantey, S. A., Taylor, J. E., Coy, D. H., Jensen, R. T., & Moran, T. H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00854-0 · Cited by 19
Effects of Growth Hormone on Body Fat in Adults
Gertner, J. M. (2008) · Hormone Research · doi:10.1159/000183761 · Cited by 19
Ba, S., Carmichael, H., & Wilson, M. (1996) · PubMed · Cited by 19
Goldberg, G. R., Prentice, A. M., Murgatroyd, P. R., Haines, W. F., & Tuersley, M. D. (1995) · PubMed · Cited by 19
Predicting the dependence liability of stimulant drugs.
Griffiths, R. R., Jv, B., & Bigelow, G. E. (1981) · PubMed · Cited by 19
Slama, G., Selmi, A., Hautecouverture, M., & Tchobroutsky, G. (1978) · PubMed · Cited by 18
Yoshida, T., Sakane, N., UMEKAWA, T., Yoshioka, K., Kondo, M., & Wakabayashi, Y. (1994) · PubMed · Cited by 18
HANSEN, B. C. (1983) · Medical Entomology and Zoology · Cited by 18
Feeding modulation by pentose and hexose analogues
Sakata, T., & Kurokawa, M. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.272s · Cited by 18
The role of brown fat in diet-induced thermogenesis.
Stock, M. J., & Rothwell, N. J. (1986) · PubMed · Cited by 18
Clinical assessment of the use of an anorectic drug in a total weight reduction program.
Hg, M. (1975) · PubMed · Cited by 18
BERTHOUD, H., & BAETTIG, K. (1974) · Physiology & Behavior · doi:10.1016/0031-9384(74)90202-9 · Cited by 17
Yoshida, T., Umekawa, T., Wakabayashi, Y., Yoshimoto, K., Sakane, N., & Kondo, M. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02764.x · Cited by 17
CASES OF MYXŒDEMA AND ACROMEGALIA TREATED WITH BENEFIT BY SHEEPʼS THYROIDS
PUTNAM, J. J. (1893) · The American Journal of the Medical Sciences · doi:10.1097/00000441-189308000-00001 · Cited by 17
Holdaway, I. M., Wallace, E. G., Westbrooke, L., & Gamble, G. D. (1995) · PubMed · Cited by 17
Greco, A. V., Mingrone, G., Capristo, E., Gaetano, A. D., Ghirlanda, G., & Castagneto, M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90212-0 · Cited by 16
Dietary obesity: Effects of drugs on food intake in S 5B/P1 and Osborne-Mendel rats
Fisler, J. S., & Bray, G. A. (1985) · Physiology & Behavior · doi:10.1016/0031-9384(85)90110-6 · Cited by 16
Self-citationThe anorectic effect of a long-acting preparation of phentermine (Duromine)
Silverstone, T. (1972) · Psychopharmacology · doi:10.1007/bf00421970 · Cited by 16
Kirkham, T. C., Gibbs, J., Smith, G. P., & Geary, N. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00044-w · Cited by 16
Effects of initial body weight on anorexia and tolerance to fenfluramine in rats
Carlton, J. R., & Rowland, N. E. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90417-4 · Cited by 16
Antiobesity and Antidiabetic β‐agonists: Lessons Learned and Questions to be Answered
Yen, T. T. T. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00095.x · Cited by 16
COMPARISON OF A NEW ANORECTIC AGENT AN 448 WITH FENFLURAMINE IN THE TREATMENT OF REFRACTORY OBESITY
Goldrick, R. B., Nestel, P. J., & Havenstein, N. (1974) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb93399.x · Cited by 16
Metabolic effects of three weeks administration of the beta-adrenoceptor agonist BRL 26830A.
Aa, C., Bennet, W. M., Jung, R. T., & Rennie, M. J. (1992) · PubMed · Cited by 16
Body weight control: The physiology, clinical treatment, and prevention of obesity
BENDER, A. E., & Brookes, L. J. (1987) · Cited by 15
Sustained‐Action Phendimetrazine in Obesity
Hadler, A. J. (1968) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1968.tb00256.x · Cited by 15
Gaal, L. F. V., Vansant, G. A. A. M., Steijaert, M., & Leeuw, I. H. D. (1995) · Metabolism · doi:10.1016/0026-0495(95)90209-0 · Cited by 15
Prolonged surveillance of dexfenfluramine in severe obesity.
Mathus-Vliegen, E. M. H. (1993) · PubMed · Cited by 15
Activation of the rat melanin-concentrating hormone neurons by ventromedial hypothalamic lesions
Deray, A., Griffond, B., Colard, C., Jacquemard, C., Bugnon, C., & FELLMANN, D. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90069-8 · Cited by 14
The Satiating Potency of Hepatic Portal Glucagon in Rats and Insulin or Insulin Antibodies
Geary, N., Asarian, L., & Langhans, W. (1997) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00361-7 · Cited by 14
Anti-hyperglycaemic mechanisms of benfluorex in type II diabetes mellitus
Feo, P. D., Bolli, G. B., Lavielle, R., & Gregoris, P. D. (1993) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610090507 · Cited by 14
Luxuskonsumption ‐ Myth or Reality?
Bray, G. A. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00180.x · Cited by 14
Self-citationDeterminants of response to anorexiants
WEINTRAUB, M. I., Taves, D. R., Hasday, J. D., et al. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.198 · Cited by 14
Blood pressure and plasma norepinephrine responses to dexfenfluramine in obese postmenopausal women
Flechtner‐Mors, M., Ditschuneit, H., Yip, I., & Adler, G. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.4.611 · Cited by 14
Carney, D. E., & Tweddell, E. D. (1975) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1975.tb118095.x · Cited by 14
Intermittent treatment with anorectic drugs.
Silverstone, T. (1974) · PubMed · Cited by 14
Effects of a combined behavioral and pharmacological program on weight loss.
Brightwell, D. R., & Cs, N. (1979) · PubMed · Cited by 14
Abramson, R., Garg, M. L., Cioffari, A., & Pa, R. (1980) · PubMed · Cited by 14
Phentermine self-administration in naive free-feeding and food-deprived rats: A dose response study
Papasava, M., Singer, G. H. S., & Papasava, C. L. (1985) · Psychopharmacology · doi:10.1007/bf00429655 · Cited by 13
Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
Ms, B., & Br, B. (1975) · PubMed · Cited by 13
Assessment of reinforcing properties of amphetamine analogues in self-administering rats.
Götestam, K. G., & Be, A. (1975) · PubMed · Cited by 13
Hypophagia induced by endogenous or liposome-encapsulated 3,4-dihydroxybutanoic acid
Terada, K., Sakata, T., Oomura, Y., Fujimoto, K., Arase, K., Osanai, T., & Nagai, Y. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90055-7 · Cited by 12
An overview of the efficacy and safety of fenfluramine and mazindol in the treatment of obesity
Stahl, K. A., & Imperiale, T. F. (1993) · Archives of Family Medicine · doi:10.1001/archfami.2.10.1033 · Cited by 12
Wilson, J. H. P., & Lamberts, S. W. J. (1981) · PubMed · Cited by 11
A Comparison of Mazindol (Teronac) with Diethylpropion in the Treatment of Exogenous Obesity
Murphy, J. E., Donald, J. F., Molla, A. L., & Crowder, D. (1975) · Journal of International Medical Research · doi:10.1177/030006057500300310 · Cited by 11
Controlled-release diethylpropion hydrochloride used in a program for weight reduction.
Wb, P. (1981) · PubMed · Cited by 11
Endocrine and Metabolic Effects of Dexfenfluramine in Patients with Android Obesity
Ditschuneit, H., Flechtner‐Mors, M., Dolderer, M., Fulda, U., & Ditschuneit, H. (1993) · Hormone and Metabolic Research · doi:10.1055/s-2007-1002180 · Cited by 11
Effectiveness of weight reduction involving "diet pills".
Wl, A., & Re, D. (1972) · PubMed · Cited by 11
A prospective controlled trial of outpatient treatment for obesity.
Gilbert, S., & Js, G. (1983) · PubMed · Cited by 11
Medeiros-Neto, G. A., Lima, N., Perozim, L. M., Pedrinola, F., & WAJCHENBERG, B. L. (1994) · Metabolism · doi:10.1016/0026-0495(94)90176-7 · Cited by 10
Evaluation of dexfenfluramine in a weight loss program for obese infertile women
Galletly, C. A., Clark, A. M., & Tomlinson, L. (1996) · International Journal of Eating Disorders · doi:10.1002/(sici)1098-108x(199603)19:2<209::aid-eat12>3.0.co;2-p · Cited by 10
Control of weight-gain during pregnancy: use of diethylpropion hydrochloride.
Boileau, P. A. (1968) · PubMed · Cited by 10
Structure-Activity Relationships of Several Amphetamine Drugs in Man
Griffith, J. D. (1977) · Advances in behavioral biology · doi:10.1007/978-1-4684-3087-5_36 · Cited by 9
Drent, M. L., Adèr, H. J., & van der Veen, E. A. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349811 · Cited by 9
DOUBLE‐BLIND TRIAL OF ANORECTIC AGENTS
Sproule, B. (1969) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1969.tb92170.x · Cited by 9
Db, C., Gordon, B. H., Ings, R. M. J., Richards, R. L., & Dw, T. (1988) · PubMed · Cited by 9
Effect of dexfenfluramine on energy expenditure in obese patients on a very-low-calorie-diet.
Recasens, M., Barenys, M., Solà, R., Blanch, S., Masana, L., & Salas‐Salvadó, J. (1995) · PubMed · Cited by 9
The treatment of obesity with drugs
Hirsch, J. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.1.2 · Cited by 8
The regeneration of d,1-fenfluramine-destroyed serotonergic nerve terminals
Westphalen, R. I., & Dodd, P. R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90874-h · Cited by 8
Effects of Enterostatin on Consumption of Optional Foods in Non‐Food‐Deprived Rats
Rice, H. B., & Corwin, R. L. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00315.x · Cited by 8
Abuse of Anorexics with Special Reference to Newer Substances
Ladewig, D., & Battegay, R. (1971) · International Journal of the Addictions · doi:10.3109/10826087109062261 · Cited by 8
Long-Term Pharmacologic Treatment of Morbid Obesity in a Community Practice
Spitz, A. F., Schumacher, D., Blank, R. C., Dhurandhar, N. V., & Atkinson, R. L. (1997) · Endocrine Practice · doi:10.4158/ep.3.5.269 · Cited by 8
Ditschuneit, H. H., Flechtner‐Mors, M., & Adler, G. (1996) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679600300411 · Cited by 8
A controlled study of a weight reduction regimen.
Noble, R. (1971) · PubMed · Cited by 8
Trial of a long-acting preparation of diethylpropion in obese diabetics.
Williams, J. (1968) · PubMed · Cited by 8
Bolding, O. T. (1968) · PubMed · Cited by 7
Zwiauer, K., Schmidinger, H., Klicpera, M., Mayr, H., & Widhalm, K. (1989) · PubMed · Cited by 7
[Thyroid hormones in the treatment of obesity].
MANTZ, O. R. (1962) · PubMed · Cited by 7
A Randomized Double‐Blind Crossover Study of the Antiobesity Effects of Etiocholanedione
Zumoff, B., Strain, G. W., Heymsfield, S. B., & Lichtman, S. W. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00038.x · Cited by 6
Weight reduction with phenmetrazine and chlorphentermine a double-blind study.
Hadler, A. J. (1967) · PubMed · Cited by 6
Mathus-Vliegen, L., & Annemieke, M. A. (1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)91652-7 · Cited by 5
Stereospecific feeding modulation by endogenous organic acid gamma-lactone in rats
Sakata, T., Terada, K., Arase, K., Fujimoto, K., Oomura, Y., Okukado, N., & Uchikawa, O. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.2.r366 · Cited by 5
Pharmacologic treatment of obesity
Jung, H. N., & Jung, C. H. (2022) · Journal of Korean Medical Association · doi:10.5124/jkma.2022.65.7.408 · Cited by 5
Cohen, A., Felice, D., Sm, L., Jg, F., Rothwell, K. G., & TRUANT, A. P. (1968) · PubMed · Cited by 4
Naloxone does not modify fenfluramine‐induced prolactin increase in obese patients
Argenio, G. F., BERNINI, G. P., Vivaldi, M. S., Corso, C. D., Santoni, R., & Franchi, F. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb00935.x · Cited by 4
Bianchi, R., Bongers, V., Bravenboer, B., & Erkelens, D. W. (1993) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610090506 · Cited by 4
A double blind controlled trial of a new anorectic agent AN448.
Woodhouse, S. P., Nye, E. R., Anderson, K., & Rawlings, J. (1975) · PubMed · Cited by 4
Russek, H. I. (1966) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196604000-00010 · Cited by 3
Williams, D. P., Boyden, T. W., Pamenter, R. W., et al. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199305001-00036 · Cited by 3
Evanselista, I. (1968) · PubMed · Cited by 3
Proietto, J. (1998) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb138997.x · Cited by 2
Weintraub, M. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350180055008 · Cited by 1
Cited by
Barlow, S. E., & and the Expert Committee (2007) · Pediatrics · doi:10.1542/peds.2007-2329c · Cited by 4,497
Lau, D. C. W., Douketis, J. D., Morrison, K. M., Hramiak, I. M., Sharma, A. M., Ur, E., & Panel, F. M. O. T. O. C. C. P. G. E. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061409 · Cited by 1,154
Recommendations for Treatment of Child and Adolescent Overweight and Obesity
Spear, B. A., Barlow, S. E., Ervin, C., Ludwig, D. S., Saelens, B. E., Schetzina, K. E., & Taveras, E. M. (2007) · Pediatrics · doi:10.1542/peds.2007-2329f · Cited by 856
Meta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Appropriate Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
JAKICIC (CHAIR), J. M., CLARK, K., COLEMAN, E., DONNELLY, J. E., FOREYT, J., MELANSON, E., VOLEK, J., & VOLPE, S. L. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200112000-00026 · Cited by 752
Metadata
- Authors
- Bray, G. A., & Greenway, F. L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1999-12-01
- Volume
- 20
- Issue
- 6
- Pages
- 805-875
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2007700773
- Cited by
- 331
- References
- 722
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.